ProMetic Life Sciences Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.2 |
Market Cap |
$337.37 M |
Shares Outstanding |
718.13 M |
Public Float |
- |
ProMetic Life Sciences Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
718.13 M |
Public Float |
- |
ProMetic Life Sciences Inc. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD262.7 |
Market Cap |
CAD399.36 M |
Shares Outstanding |
23.22 B |
Public Float |
559.92 M |
Address |
440 Armand-Frappier Boulevard Laval Québec H7V 4B4 Canada |
Employees | - |
Website | http://www.prometic.com |
Updated | 07/04/2019 |
Prometic Life Sciences, Inc. engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation, and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment is involved in large-scale purification of biologics and the elimination of pathogens. |